05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lynda Vrooman, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Centre de Recherche Du Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, Canada
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
New York, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
The Bronx, New York, United States
- Hasbro Children'S Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2005
- Primary completion
- 31 Aug 2014
- Completion
- 30 Jun 2019
- Last update posted
- 13 Feb 2026
- Registered enrollment
- 800
- Registry id
- NCT00400946
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.